Indutrade, a UK-based technology and industrial business group, has signed an agreement to acquire all shares in IPP Industrial Production Processes.
IPP Industrial Production Processes is an Ireland-based technical trading company specialising in advanced manufacturing equipment and consumables for the pharmaceutical, medical device, and electronics industries.
IPP’s annual sales amount to approximately €17 million (SEK 185 million).
Founded in 1976, IPP supplies high-specification solutions that support compliant and efficient clean manufacturing processes. Its portfolio includes non-destructive package testing systems, packaging equipment, and track-and-trace technologies — all critical for regulated environments in the life sciences sector.
The acquisition, subject to regulatory approval, is expected to close in Q2 2025
The company also offers surface mount and final assembly equipment for electronics manufacturing, backed by aftermarket support services.
With 29 employees across sites in Cork, Ireland, and Bromsgrove, UK, IPP will be integrated into Indutrade’s Business Area Life Science.
The acquisition, subject to regulatory approval, is expected to close in Q2 2025.
IPP’s annual sales amount to approximately €17 million (SEK 185 million)
Bo Annvik, President and CEO of Indutrade, said: “IPP has a proven record of sustainable, profitable growth, built on technical expertise and a strong customer service ethos. The company is a strategic and cultural fit for Indutrade, and we’re pleased to welcome them to the Group.”
This acquisition marks Indutrade’s second of the year and is expected to have a marginally positive impact on earnings per share.
It also signals Indutrade’s continued investment in cleanroom-relevant technologies for regulated manufacturing sectors.